{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T13:11:19Z","timestamp":1775308279505,"version":"3.50.1"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Immunology"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.cellimm.2020.104187","type":"journal-article","created":{"date-parts":[[2020,7,28]],"date-time":"2020-07-28T13:19:17Z","timestamp":1595942357000},"page":"104187","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["New disease old vaccine: Is recombinant BCG vaccine an answer for COVID-19?"],"prefix":"10.1016","volume":"356","author":[{"given":"Pramod Kumar","family":"Gupta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cellimm.2020.104187_b0005","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","article-title":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.cellimm.2020.104187_b0010","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.cell.2020.03.035","article-title":"A genomic perspective on the origin and emergence of SARS-CoV-2","volume":"181","author":"Zhang","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.cellimm.2020.104187_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2020.102433","article-title":"The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak","volume":"109","author":"Rothan","year":"2020","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.cellimm.2020.104187_b0020","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.cellimm.2020.104187_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2020.03.007","article-title":"SARS-CoV-2 vaccines: status report","author":"Amanat","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.cellimm.2020.104187_b0030","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41579-018-0118-9","article-title":"Origin and evolution of pathogenic coronaviruses","volume":"17","author":"Cui","year":"2019","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.cellimm.2020.104187_b0035","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41586-020-2008-3","article-title":"A new coronavirus associated with human respiratory disease in China","volume":"579","author":"Wu","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.cellimm.2020.104187_b0040","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nrmicro.2016.81","article-title":"SARS and MERS: recent insights into emerging coronaviruses","volume":"14","author":"de Wit","year":"2016","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.cellimm.2020.104187_b0045","doi-asserted-by":"crossref","unstructured":"W. Tai, L. He, X. Zhang, J. Pu, D. Voronin, S. Jiang, Y. Zhou, L. Du, Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine, Cell. Mol. Immunol., (2020).","DOI":"10.1038\/s41423-020-0400-4"},{"key":"10.1016\/j.cellimm.2020.104187_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2020.02.058","article-title":"Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein","author":"Walls","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.cellimm.2020.104187_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.it.2020.02.007","article-title":"SARS coronavirus redux","author":"Qing","year":"2020","journal-title":"Trends Immunol."},{"key":"10.1016\/j.cellimm.2020.104187_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.chom.2020.03.002","article-title":"A sequence homology and bioinformatic approach can predict candidate targets for immune responses to SARS-CoV-2","author":"Grifoni","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.cellimm.2020.104187_b0065","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/j.cmi.2019.04.020","article-title":"Non-specific effects of BCG vaccine on viral infections","volume":"25","author":"Moorlag","year":"2019","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.cellimm.2020.104187_b0070","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.chom.2017.12.010","article-title":"BCG vaccination protects against experimental viral infection in humans through the induction of cytokines associated with trained immunity","volume":"23","author":"Arts","year":"2018","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.cellimm.2020.104187_b0075","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.clinthera.2013.01.007","article-title":"Nonspecific effects of vaccines and the reduction of mortality in children","volume":"35","author":"Shann","year":"2013","journal-title":"Clin. Ther."},{"key":"10.1016\/j.cellimm.2020.104187_b0080","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.02806","article-title":"BCG-induced cross-protection and development of trained immunity: implication for vaccine design","volume":"10","author":"Covi\u00e1n","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cellimm.2020.104187_b0085","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/ije\/dyh392","article-title":"BCG vaccination scar associated with better childhood survival in Guinea-Bissau","volume":"34","author":"Roth","year":"2005","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.cellimm.2020.104187_b0090","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/infdis\/jir240","article-title":"Randomized trial of BCG vaccination at birth to low-birth-weight children: beneficial nonspecific effects in the neonatal period?","volume":"204","author":"Aaby","year":"2011","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.cellimm.2020.104187_b0095","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/INF.0b013e3182458289","article-title":"Small randomized trial among low-birth-weight children receiving bacillus Calmette-Gu\u00e9rin vaccination at first health center contact","volume":"31","author":"Biering-S\u00f8rensen","year":"2012","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.cellimm.2020.104187_b0100","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.vaccine.2004.09.006","article-title":"Acute lower respiratory tract infections and respiratory syncytial virus in infants in Guinea-Bissau: a beneficial effect of BCG vaccination for girls community based case-control study","volume":"23","author":"Stensballe","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.cellimm.2020.104187_b0105","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.urology.2005.12.014","article-title":"Can intravesical bacillus Calmette-Guerin reduce recurrence in patients with superficial bladder cancer? A meta-analysis of randomized trials","volume":"67","author":"Han","year":"2006","journal-title":"Urology"},{"key":"10.1016\/j.cellimm.2020.104187_b0110","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1093\/infdis\/jiv332","article-title":"BCG vaccination enhances the immunogenicity of subsequent influenza vaccination in healthy volunteers: A randomized, placebo-controlled pilot study","volume":"212","author":"Leentjens","year":"2015","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.cellimm.2020.104187_b0115","first-page":"34","article-title":"[Prevention of elderly pneumonia by pneumococcal, influenza and BCG vaccinations]","volume":"42","author":"Ohrui","year":"2005","journal-title":"Nihon Ronen Igakkai zasshi. Jpn. J. Geriatr."},{"key":"10.1016\/j.cellimm.2020.104187_b0120","first-page":"185","article-title":"The efficacy of Bacillus Calmette-Guerin vaccinations for the prevention of acute upper respiratory tract infection in the elderly","volume":"43","author":"Wardhana","year":"2011","journal-title":"Acta Med. Indones."},{"key":"10.1016\/j.cellimm.2020.104187_b0125","doi-asserted-by":"crossref","unstructured":"E. Nemes, H. Geldenhuys, V. Rozot, K.T. Rutkowski, F. Ratangee, N. Bilek, S. Mabwe, L. Makhethe, M. Erasmus, A. Toefy, H. Mulenga, W.A. Hanekom, S.G. Self, L.G. Bekker, R. Ryall, S. Gurunathan, C.A. DiazGranados, P. Andersen, I. Kromann, T. Evans, R.D. Ellis, B. Landry, D.A. Hokey, R. Hopkins, A.M. Ginsberg, T.J. Scriba, M. Hatherill, C.S. Team, Prevention of M. tuberculosis infection with H4:IC31 vaccine or BCG revaccination, N. Engl. J. Med., 379 (2018) 138\u2013149.","DOI":"10.1056\/NEJMoa1714021"},{"key":"10.1016\/j.cellimm.2020.104187_b0130","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.cell.2020.04.042","article-title":"Trained immunity: a tool for reducing susceptibility to and the severity of SARS-CoV-2 infection","volume":"181","author":"Netea","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.cellimm.2020.104187_b0135","doi-asserted-by":"crossref","unstructured":"A. Miller, M.J. Reandelar, K. Fasciglione, V. Roumenova, Y. Li, G.H. Otazu, Correlation between universal BCG vaccination policy and reduced morbidity and mortality for COVID-19: an epidemiological study, medRxiv, (2020) 2020.2003.2024.20042937.","DOI":"10.1101\/2020.03.24.20042937"},{"key":"10.1016\/j.cellimm.2020.104187_b0140","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.clim.2014.10.005","article-title":"BCG-induced trained immunity in NK cells: Role for non-specific protection to infection","volume":"155","author":"Kleinnijenhuis","year":"2014","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.cellimm.2020.104187_b0145","doi-asserted-by":"crossref","first-page":"17537","DOI":"10.1073\/pnas.1202870109","article-title":"Bacille Calmette-Gu\u00e9rin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes","volume":"109","author":"Kleinnijenhuis","year":"2012","journal-title":"PNAS"},{"key":"10.1016\/j.cellimm.2020.104187_b0150","doi-asserted-by":"crossref","unstructured":"M.G. Netea, L.A. Joosten, E. Latz, K.H. Mills, G. Natoli, H.G. Stunnenberg, L.A. O'Neill, R.J. Xavier, Trained immunity: A program of innate immune memory in health and disease, Science, 352 (2016) aaf1098.","DOI":"10.1126\/science.aaf1098"},{"key":"10.1016\/j.cellimm.2020.104187_b0155","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/s41577-020-0285-6","article-title":"Defining trained immunity and its role in health and disease","volume":"20","author":"Netea","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cellimm.2020.104187_b0160","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1146\/annurev-immunol-031210-101303","article-title":"Chromatin contributions to the regulation of innate immunity","volume":"32","author":"Smale","year":"2014","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.cellimm.2020.104187_b0165","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.immuni.2010.02.008","article-title":"Identification and characterization of enhancers controlling the inflammatory gene expression program in macrophages","volume":"32","author":"Ghisletti","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.cellimm.2020.104187_b0170","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.cell.2007.02.005","article-title":"Chromatin modifications and their function","volume":"128","author":"Kouzarides","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.cellimm.2020.104187_b0175","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s00281-019-00731-w","article-title":"Regulation of T cell differentiation and function by epigenetic modification enzymes","volume":"41","author":"Liu","year":"2019","journal-title":"Sem. Immunopathol."},{"key":"10.1016\/j.cellimm.2020.104187_b0180","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1189\/jlb.4MA0215-059R","article-title":"Long-term in vitro and in vivo effects of gamma-irradiated BCG on innate and adaptive immunity","volume":"98","author":"Arts","year":"2015","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.cellimm.2020.104187_b0185","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/trstmh\/tru168","article-title":"Trained immunity: consequences for the heterologous effects of BCG vaccination","volume":"109","author":"Kleinnijenhuis","year":"2015","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.cellimm.2020.104187_b0190","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/j.cell.2018.11.007","article-title":"Trained immunity and local innate immune memory in the lung","volume":"175","author":"Netea","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.cellimm.2020.104187_b0195","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1016\/j.celrep.2016.11.011","article-title":"Immunometabolic pathways in BCG-induced trained immunity","volume":"17","author":"Arts","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.cellimm.2020.104187_b0200","doi-asserted-by":"crossref","first-page":"1250684","DOI":"10.1126\/science.1250684","article-title":"mTOR- and HIF-1\u03b1\u2013mediated aerobic glycolysis as metabolic basis for trained immunity","volume":"345","author":"Cheng","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.cellimm.2020.104187_b0205","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.cmet.2016.10.008","article-title":"Glutaminolysis and fumarate accumulation integrate immunometabolic and epigenetic programs in trained immunity","volume":"24","author":"Arts","year":"2016","journal-title":"Cell Metab."},{"key":"10.1016\/j.cellimm.2020.104187_b0210","doi-asserted-by":"crossref","unstructured":"S. Bekkering, R.J.W. Arts, B. Novakovic, I. Kourtzelis, C. van der Heijden, Y. Li, C.D. Popa, R. Ter Horst, J. van Tuijl, R.T. Netea-Maier, F.L. van de Veerdonk, T. Chavakis, L.A.B. Joosten, J.W.M. van der Meer, H. Stunnenberg, N.P. Riksen, M.G. Netea, Metabolic induction of trained immunity through the mevalonate pathway, Cell, 172 (2018) 135\u2013146 e139.","DOI":"10.1016\/j.cell.2017.11.025"},{"key":"10.1016\/j.cellimm.2020.104187_b0215","doi-asserted-by":"crossref","unstructured":"I. Mitroulis, K. Ruppova, B. Wang, L.S. Chen, M. Grzybek, T. Grinenko, A. Eugster, M. Troullinaki, A. Palladini, I. Kourtzelis, A. Chatzigeorgiou, A. Schlitzer, M. Beyer, L.A.B. Joosten, B. Isermann, M. Lesche, A. Petzold, K. Simons, I. Henry, A. Dahl, J.L. Schultze, B. Wielockx, N. Zamboni, P. Mirtschink, U. Coskun, G. Hajishengallis, M.G. Netea, T. Chavakis, Modulation of myelopoiesis progenitors is an integral component of trained immunity, Cell, 172 (2018) 147\u2013161 e112.","DOI":"10.1016\/j.cell.2017.11.034"},{"key":"10.1016\/j.cellimm.2020.104187_b0220","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/s41590-019-0402-5","article-title":"Hematopoietic progenitor cells as integrative hubs for adaptation to and fine-tuning of inflammation","volume":"20","author":"Chavakis","year":"2019","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cellimm.2020.104187_b0225","doi-asserted-by":"crossref","unstructured":"E. Kaufmann, J. Sanz, J.L. Dunn, N. Khan, L.E. Mendonca, A. Pacis, F. Tzelepis, E. Pernet, A. Dumaine, J.C. Grenier, F. Mailhot-Leonard, E. Ahmed, J. Belle, R. Besla, B. Mazer, I.L. King, A. Nijnik, C.S. Robbins, L.B. Barreiro, M. Divangahi, BCG educates hematopoietic stem cells to generate protective innate immunity against tuberculosis, Cell, 172 (2018) 176\u2013190 e119.","DOI":"10.1016\/j.cell.2017.12.031"},{"key":"10.1016\/j.cellimm.2020.104187_b0230","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nri.2016.43","article-title":"Harnessing the beneficial heterologous effects of vaccination","volume":"16","author":"Goodridge","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cellimm.2020.104187_b0235","doi-asserted-by":"crossref","first-page":"3528","DOI":"10.1128\/JVI.02393-08","article-title":"CD4 T-cell-mediated heterologous immunity between mycobacteria and poxviruses","volume":"83","author":"Mathurin","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.cellimm.2020.104187_b0240","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1159\/000355628","article-title":"Long-lasting effects of BCG vaccination on both heterologous Th1\/Th17 responses and innate trained immunity","volume":"6","author":"Kleinnijenhuis","year":"2014","journal-title":"J. Innate Immun."},{"key":"10.1016\/j.cellimm.2020.104187_b0245","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2478\/folmed-2013-0005","article-title":"Immunomodulatory effects of BCG in patients with recurrent respiratory papillomatosis","volume":"55","author":"Vetskova","year":"2013","journal-title":"Folia Med."},{"key":"10.1016\/j.cellimm.2020.104187_b0250","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1586\/14760584.2015.1068124","article-title":"Applications of bacillus Calmette-Guerin and recombinant bacillus Calmette-Guerin in vaccine development and tumor immunotherapy","volume":"14","author":"Zheng","year":"2015","journal-title":"Expert Rev. Vacc."},{"key":"10.1016\/j.cellimm.2020.104187_b0255","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.4049\/jimmunol.168.4.1869","article-title":"Cell-mediated immunity induced by recombinant <em>Mycobacterium bovis<\/em> Bacille Calmette-Gu\u00e9rin strains against an intracellular bacterial pathogen: importance of antigen secretion or membrane-targeted antigen display as lipoprotein for vaccine efficacy","volume":"168","author":"Grode","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2020.104187_b0260","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1093\/infdis\/jir592","article-title":"Recombinant BCG \u0394ureC hly+ induces superior protection over parental BCG by stimulating a balanced combination of type 1 and type 17 cytokine responses","volume":"204","author":"Desel","year":"2011","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.cellimm.2020.104187_b0265","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1093\/infdis\/jiu675","article-title":"The recombinant BCG \u0394ureC::hly vaccine targets the AIM2 inflammasome to induce autophagy and inflammation","volume":"211","author":"Saiga","year":"2014","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.cellimm.2020.104187_b0270","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1006\/clim.2002.5292","article-title":"Oral recombinant Mycobacterium bovis bacillus Calmette-Guerin expressing HIV-1 antigens as a freeze-dried vaccine induces long-term, HIV-specific mucosal and systemic immunity","volume":"105","author":"Kawahara","year":"2002","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.cellimm.2020.104187_b0275","doi-asserted-by":"crossref","first-page":"5151","DOI":"10.1128\/JVI.03178-12","article-title":"Robust immunity to an auxotrophic Mycobacterium bovis BCG-VLP prime-boost HIV vaccine candidate in a nonhuman primate model","volume":"87","author":"Chege","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.cellimm.2020.104187_b0280","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1007\/s00705-008-0082-1","article-title":"A novel hepatitis C virus vaccine approach using recombinant Bacillus Calmette-Guerin expressing multi-epitope antigen","volume":"153","author":"Wei","year":"2008","journal-title":"Arch. Virol."},{"key":"10.1016\/j.cellimm.2020.104187_b0285","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.3389\/fimmu.2018.02875","article-title":"Recombinant BCG vaccines reduce pneumovirus-caused airway pathology by inducing protective humoral immunity","volume":"9","author":"Soto","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cellimm.2020.104187_b0290","doi-asserted-by":"crossref","first-page":"5578","DOI":"10.1016\/j.vaccine.2011.09.054","article-title":"A recombinant Bacille Calmette-Guerin construct expressing the Plasmodium falciparum circumsporozoite protein enhances dendritic cell activation and primes for circumsporozoite-specific memory cells in BALB\/c mice","volume":"30","author":"Arama","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.cellimm.2020.104187_b0295","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.parint.2007.04.003","article-title":"Immune response induced by recombinant Mycobacterium bovis BCG expressing ROP2 gene of Toxoplasma gondii","volume":"56","author":"Wang","year":"2007","journal-title":"Parasitol. Int."},{"key":"10.1016\/j.cellimm.2020.104187_b0300","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1128\/IAI.70.1.303-314.2002","article-title":"Plasmidic versus insertional cloning of heterologous genes in <em>Mycobacterium bovis<\/em> BCG: impact on in vivo antigen persistence and immune responses","volume":"70","author":"M\u00e9derl\u00e9","year":"2002","journal-title":"Infect. Immun."},{"key":"10.1016\/j.cellimm.2020.104187_b0305","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.00923","article-title":"Priming with recombinant BCG expressing novel HIV-1 conserved mosaic immunogens and boosting with recombinant ChAdOx1 is safe, stable, and elicits HIV-1-specific T-cell responses in BALB\/c mice","volume":"10","author":"Kilpel\u00e4inen","year":"2019","journal-title":"Front. Immunol."}],"container-title":["Cellular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008874920303476?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008874920303476?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T23:02:46Z","timestamp":1757804566000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0008874920303476"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":61,"alternative-id":["S0008874920303476"],"URL":"https:\/\/doi.org\/10.1016\/j.cellimm.2020.104187","relation":{},"ISSN":["0008-8749"],"issn-type":[{"value":"0008-8749","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New disease old vaccine: Is recombinant BCG vaccine an answer for COVID-19?","name":"articletitle","label":"Article Title"},{"value":"Cellular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellimm.2020.104187","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104187"}}